Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · Real-Time Price · USD
18.84
-1.24 (-6.18%)
May 13, 2025, 4:00 PM - Market closed

Dianthus Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
10.1222.79132.3315.377.64
Short-Term Investments
253.11252.4541.3960.13-
Cash & Short-Term Investments
263.23275.24173.7275.497.64
Cash Growth
-30.18%58.44%130.12%888.35%-
Receivables
10.810.485.641.48
Inventory
4.313.042.160.820.24
Prepaid Expenses
2.071.471.10.090.02
Other Current Assets
0.390.36--0.01
Total Current Assets
271280.9177.4582.039.39
Property, Plant & Equipment
1.641.750.80.960.03
Long-Term Investments
68.3181.73---
Other Long-Term Assets
7.649.631.150.120.03
Total Assets
348.58374.01179.4183.119.45
Accounts Payable
8.274.582.611.171.36
Accrued Expenses
7.9813.076.56.613.99
Current Portion of Leases
0.230.320.420.35-
Current Unearned Revenue
0.480.480.10.1-
Total Current Liabilities
16.9518.459.638.235.35
Long-Term Leases
1.171.170.170.44-
Long-Term Unearned Revenue
1.851.910.740.79-
Total Liabilities
19.9721.5310.549.455.35
Common Stock
0.030.030.02--
Additional Paid-In Capital
532.21526.73258.231.660.14
Retained Earnings
-203.9-174.39-89.42-45.87-17.39
Comprehensive Income & Other
0.270.110.05-0.16-
Total Common Equity
328.61352.48168.87-44.37-17.25
Shareholders' Equity
328.61352.48168.8773.664.1
Total Liabilities & Equity
348.58374.01179.4183.119.45
Total Debt
1.41.490.590.79-
Net Cash (Debt)
330.14355.48173.1374.77.64
Net Cash Growth
-12.32%105.32%131.76%878.03%-
Net Cash Per Share
9.2110.6733.6085.451.91
Filing Date Shares Outstanding
32.1632.1329.354.014.01
Total Common Shares Outstanding
32.1331.1214.824.014.01
Working Capital
254.05262.45167.8273.814.04
Book Value Per Share
10.2311.3311.40-11.05-4.31
Tangible Book Value
328.61352.48168.87-44.37-17.25
Tangible Book Value Per Share
10.2311.3311.40-11.05-4.31
Machinery
0.410.390.280.17-
Construction In Progress
----0.03
Updated May 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q